CiteULike: Zephyrus's Allred:DC [9 articles]

The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer.

Breast Cancer Res, Vol. 6, No. 6. (2004), pp. 240-245.

posted to cancer estrogen-receptor origins proliferation breast thelist superlist by Zephyrus on 2009-06-17 15:57:13 as

Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes.

Cancer research, Vol. 66, No. 18. (15 September 2006), pp. 9308-9315.

by J. C. Harrell, W. W. Dye, D. C. Allred, et al.P. Jedlicka, N. S. Spoelstra, C. A. Sartorius, K. B. Horwitz

posted to cancer cd44 lymph metastasis node breast thelist by Zephyrus on 2009-06-05 17:32:47 as

Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.

Journal of the National Cancer Institute, Vol. 90, No. 9. (6 May 1998), pp. 697-703.

by P. O'Connell, V. Pekkel, S. A. Fuqua, C. K. Osborne, G. M. Clark, D. C. Allred

posted to cancer genetic pre-malignant breast thelist superlist by Zephyrus on 2009-06-04 18:31:56 as

Histological and biological evolution of human premalignant breast disease.

Endocrine-related cancer, Vol. 8, No. 1. (March 2001), pp. 47-61.

by D. C. Allred, S. K. Mohsin, S. A. Fuqua

posted to cancer evolution pre-malignant review breast thelist superlist by Zephyrus on 2009-06-04 17:19:01 as

Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.

Archives of pathology & laboratory medicine, Vol. 124, No. 7. (July 2000), pp. 966-978.

by P. L. Fitzgibbons, D. L. Page, D. Weaver, et al.A. D. Thor, D. C. Allred, G. M. Clark, S. G. Ruby, F. O'Malley, J. F. Simpson, J. L. Connolly, D. F. Hayes, S. B. Edge, A. Lichter, S. J. Schnitt

posted to cancer factors prognosis-bc breast thelist superlist by Zephyrus on 2009-04-28 21:21:19 as

Breast cancer.

Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 7, No. 2. (February 2009), pp. 122-192.

posted to cancer guidelines nccn breast thelist by Zephyrus on 2009-03-07 20:29:23 as

HER2 testing in breast cancer: NCCN Task Force report and recommendations.

Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 4 Suppl 3 (July 2006)

by R. W. Carlson, S. J. Moench, M. E. Hammond, et al.E. A. Perez, H. J. Burstein, D. C. Allred, C. L. Vogel, L. J. Goldstein, G. Somlo, W. J. Gradishar, C. A. Hudis, M. Jahanzeb, A. Stark, A. C. Wolff, M. F. Press, E. P. Winer, S. Paik, B. M. Ljung,

posted to background dod her2 list thelist superlist by Zephyrus on 2009-03-07 20:19:09 as

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 17, No. 5. (May 1999), pp. 1474-1481.

by J. M. Harvey, G. M. Clark, C. K. Osborne, D. C. Allred

posted to allred background dod er ihc list thelist superlist by Zephyrus on 2009-03-07 20:11:02 as

along with 1 person songpku

Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution.

Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, No. 2. (15 January 2008), pp. 370-378.

by D. C. Allred, Y. Wu, S. Mao, et al.I. D. Nagtegaal, S. Lee, C. M. Perou, S. K. Mohsin, P. O'Connell, A. Tsimelzon, D. Medina

posted to cancer dcis diversity evolution progression breast thelist by Zephyrus on 2008-09-11 15:17:21 as

along with 1 person and 3 groups songpku Breast Cancer Reading Club Breast cancer Roswell Cancer Crosstalk

	The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer. [My Copy] Breast Cancer Res, Vol. 6, No. 6. (2004), pp. 240-245. by D. C. Allred, P. Brown, D. Medina posted to cancer estrogen-receptor origins proliferation breast thelist superlist by Zephyrus on 2009-06-17 15:57:13 as along with 2 people jfr horishin
	Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes. [My Copy] Cancer research, Vol. 66, No. 18. (15 September 2006), pp. 9308-9315. by J. C. Harrell, W. W. Dye, D. C. Allred, et al.P. Jedlicka, N. S. Spoelstra, C. A. Sartorius, K. B. Horwitz posted to cancer cd44 lymph metastasis node breast thelist by Zephyrus on 2009-06-05 17:32:47 as
	Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. [My Copy] Journal of the National Cancer Institute, Vol. 90, No. 9. (6 May 1998), pp. 697-703. by P. O'Connell, V. Pekkel, S. A. Fuqua, C. K. Osborne, G. M. Clark, D. C. Allred posted to cancer genetic pre-malignant breast thelist superlist by Zephyrus on 2009-06-04 18:31:56 as
	Histological and biological evolution of human premalignant breast disease. [My Copy] Endocrine-related cancer, Vol. 8, No. 1. (March 2001), pp. 47-61. by D. C. Allred, S. K. Mohsin, S. A. Fuqua posted to cancer evolution pre-malignant review breast thelist superlist by Zephyrus on 2009-06-04 17:19:01 as
	Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. [My Copy] Archives of pathology & laboratory medicine, Vol. 124, No. 7. (July 2000), pp. 966-978. by P. L. Fitzgibbons, D. L. Page, D. Weaver, et al.A. D. Thor, D. C. Allred, G. M. Clark, S. G. Ruby, F. O'Malley, J. F. Simpson, J. L. Connolly, D. F. Hayes, S. B. Edge, A. Lichter, S. J. Schnitt posted to cancer factors prognosis-bc breast thelist superlist by Zephyrus on 2009-04-28 21:21:19 as
	Breast cancer. [My Copy] Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 7, No. 2. (February 2009), pp. 122-192. by R. W. Carlson, D. C. Allred, B. O. Anderson, et al.H. J. Burstein, W. B. Carter, S. B. Edge, J. K. Erban, W. B. Farrar, L. J. Goldstein, W. J. Gradishar, D. F. Hayes, C. A. Hudis, M. Jahanzeb, K. Kiel, B. M. Ljung, P. K. Marcom, I. A. Mayer, B. McCormick, L. M. Nabell, L. J. Pierce, E. C. Reed, M. L. Smith, G. Somlo, R. L. Theriault, N. S. Topham, J. H. Ward, E. P. Winer, A. C. Wolff, posted to cancer guidelines nccn breast thelist by Zephyrus on 2009-03-07 20:29:23 as
	HER2 testing in breast cancer: NCCN Task Force report and recommendations. [My Copy] Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 4 Suppl 3 (July 2006) by R. W. Carlson, S. J. Moench, M. E. Hammond, et al.E. A. Perez, H. J. Burstein, D. C. Allred, C. L. Vogel, L. J. Goldstein, G. Somlo, W. J. Gradishar, C. A. Hudis, M. Jahanzeb, A. Stark, A. C. Wolff, M. F. Press, E. P. Winer, S. Paik, B. M. Ljung, posted to background dod her2 list thelist superlist by Zephyrus on 2009-03-07 20:19:09 as
	Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 17, No. 5. (May 1999), pp. 1474-1481. by J. M. Harvey, G. M. Clark, C. K. Osborne, D. C. Allred posted to allred background dod er ihc list thelist superlist by Zephyrus on 2009-03-07 20:11:02 as along with 1 person songpku
	Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, No. 2. (15 January 2008), pp. 370-378. by D. C. Allred, Y. Wu, S. Mao, et al.I. D. Nagtegaal, S. Lee, C. M. Perou, S. K. Mohsin, P. O'Connell, A. Tsimelzon, D. Medina posted to cancer dcis diversity evolution progression breast thelist by Zephyrus on 2008-09-11 15:17:21 as along with 1 person and 3 groups songpku Breast Cancer Reading Club Breast cancer Roswell Cancer Crosstalk

Zephyrus's Allred:DC [9 articles] Export

Zephyrus's tags

thelist	2230
cancer	1844
breast	1489
superlist	1351
estrogen	711
review	643
background	441
evolution	357
read	328
cancer-crosstalk	251
treg	243
aggressiveness	229
xenoestrogen	217
methods	197
th2	197
immunomodulation	195
th1	194
hormone	184
immunology	157
dod	154
justification	149
therapy	145
autoimmune	139
genetics	139
immune	138
inflammation	136
gene-expression	135
epidemiology	134
mitochondria	131
receptor	128
metastasis	126
statistics	126
estrogen-receptor	126
prognosis	124
t-cell	122
list	113
primer	110
assay	105
confounder	102
endocrine	102
tumour	101
development	93
grade	89
epigenetics	88
aggressiveness-prediction	88
measurement	87
new-direction	84
apoptosis	81
disease	80
evolepi	79
mechanism	76
microarray	75
balance	73
obesity	69
molecular	66
africa	63
genetic	63
pregnancy	63
basal	63
cytokine	63
treg-background	63
polarization	62
interesting	62
check	62
pathway	61
survival	60
urgent	59
stress	58
neuroendocrine	57
signature	55
gwas	55
microenvironment	54
steroid	54
mice	53
risk	53
perspective	53
top	52
african-american	52
reproductive	52
gender-differences	52
cell	52
new-assay	51
interaction	50
environment	50
estrogen-tregs	49
pathology	49
genes	48
blood	47
progression	47
population	47
fetal	46
heterogeneity	45
hrt	45
disruption	44
prenatal	44
wira	43
regulation	43
phytoestrogen	43
dendritic	41
nutrition	41
selection	41
progesterone	40
model	40
prediction	40
immunosenescence	39
response	39
genomics	38
tools	38
snp	38
adipose	38
dna	38
senescence	37
th17	37
variation	37
natal	35
age	35
treg-cancer	35
microbiome	34
infection	33
ms	33
diet	32
plasticity	31
bcdc	31
estrogenicity	31
peripheral	31
comparisons	30
biology	30
signalling	30
research	30
web-study	30
metabolism	29
her2	29
immunotherapy	29
analysis	28
function	28
disparities	28
biomarker	28
involution	28
transcription	28
suppression	28
energy	28
gender	27
eae	27
carcinogenesis	27
phenotype	27
ley	27
association	27
polymorphisms	26
postmenopausal	26
lymph	25
subsets	25
cnv	25
tamoxifen	25
dcis	25
foxp3	25
prostate	25
xenobiotic	25
allergy	25
behaviour	24
commentary	24
hypothesis	24
morphology	24
receptor-status	24
methylation	23
exposure	23
macrophage	23
comparison	23
diabetes	23
uterine	23
defref	23
prolactin	23
reproduction	23
brca	23
classification	23
risk-factors	22
proliferation	22
microrna	22
hereditary	22
triple-negative	22
pre-malignant	22
toll-like-receptor	22
genome	22
target	22
gut	22
mtdna	22
insulin	22
human	22
vitd	21
negative	21
assay-defence	21
chemotherapy	21
b-cell	21
prevention	21
resistance	21
node	21
angiogenesis	21
characteristics	20
sle	20
subtypes	20
hiv	20
differentiation	20
estrogen-immune	20
guidelines	19
microbiota	19
uterus	19
stem-cell	19
histology	19
race	19
journal-club	19
immunity	19
growth	19
bone	19
treg-bc	18
16q	18
validation	18
height	18
protein	18
outcome	18
male	18
system	18
detection	18
power	17
vaccine	17
lung	17
cd4	17
gene-environment	17
cgh	17
infectious	17
ageing	17
stage	17
migrant	17
expression	17
epithelium	17
guidance	17
tissue	17
menopause	16
autoimmunity	16
factors	16
antioxidant	16
incidence	16
malaria	16
premenopausal	16
tgfb	16
presentation	15
gene-list	15
lifespan	15
usage	15
serum	15
ctc	15
mammography	15
aryl-hc	15
collinearity	15
ra	15
thymus	15
immune-system	15
immune-evasion	15
tolerance	15
mutation	15
nuclear	15
for:songpku	14
susceptibility	14
read-today	14
chemokines	14
nigeria	14
assessment	14
escreen	14
maternal	14
progesterone-receptor	14
size	13
studies	13
lymphocyte	13
metabolic	13
data-analysis	13
dormancy	13
clinical	13
estradiol	13
signaling	13
beta	13
xenoestrogen-immune	13
disruptors	13
book	13
regression	13
prognosis-bc	13
er-calux	13
sample-size	13
warburg	13
cell-cycle	13
testosterone	13
homeostasis	12
outbreak	12
brain	12
in-vitro	12
nottingham	12
cardiac	12
mcf-7	12
programming	12
advice	12
ifn-gamma	12
database	12
genistein	12
homework	12
genetic-basis	12
innate	12
reference	12
death	12
aromatase	12
case-control	12
genotype	12
histopathology	12
restriction	12
grade-is-best	12
action	12
mortality	11
growth-factors	11
caucasian	11
melanoma	11
gene-gene-interactions	11
ki67	11
mixture-effects	11
markers	11
nsaid	11
instability	11
tnfa	11
grade-prognosis	11
physiology	11
neonatal	11
latent	11
distinction	11
androgen	11
screening	11
il17	11
ses	11
endemic	11
plasma	11
leukocytes	10
diversity	10
software	10
correlation	10
heterogeneity-bc	10
soy	10
neutrophil	10
dtc	10
colorectal	10
apc	10
er	10
menarche	10
opinion	10
til	10
nk-cells	10
proteomics	10
endometriosis	10
complex	10
haplotype	10
bioinformatics	10
pituitary	10
xenoestrogen-bc	10
immunohistochemistry	10
bacteria	10
pathogenesis	10
surgery	9
smoking	9
clinical-significance	9
adaptive	9
leptin	9
estrogen-basic	9
levels	9
cell-death	9
brca1	9
traffic	9
cytokeratin	9
reliability	9
stroma	9
anti-inflammatory	9
mapping	9
distribution	9
outcomes	9
profile	9
nf-kappab	9
pregnancy-associated-breast-cancer	9
density	9
science	9
activation	9
bone-marrow	9
breast-feeding	9
amplification	9
il6	9
future	9
nitric-oxide	9
factor	9
hypoxia	9
lobular	9
ancestry	9
toxicology	9
pathways	9
fat	9
il4	9
general	8
isoflavone	8
mammary	8
tumor	8
editorial	8
calorie	8
status	8
emt	8
limitations	8
candidate	8
il2	8
etiology	8
perinatal	8
pca	8
stem	8
old-wine-new-bottle	8
alcohol	8
modulation	8
estrogen-level	8
diagnosis	8
starting-point	8
cox2	8
protocol	8
iron	8
migration	8
repair	8
future-research	8
ere	8
rna	8
origin	8
p53	8
seer	8
darwin	8
meta-analysis	8
ethnicity	8
recurrence	8
oxidative	8
european	8
flow-cytometry	8
er-alpha	8
weight	8
esr1	7
public-abstract	7
gene-reporter	7
imprinting	7
axis	7
nodes	7
ahr	7
brca2	7
asthma	7
immunotoxicity	7
origins	7
demography	7
writing	7
significance	7
concepts	7
trends	7
virus	7
positive	7
inflammatory	7
estrogen-action	7
bisphenol-a	7
melatonin	7
syndrome	7
predictive-adaptive	7
cmi	7
critique	7
feto-maternal	7
menstruation	7
antigen	7
effects	7
pd-1	7
endogenous	7
inuit	7
history	7
resource	7
postnatal	7
yeast	7
damage	7
er-beta	7
lifestyle	7
environmental	7
additivity	7
organogenesis	7
asian	7
impact	7
dysfunction	7
ros	7
identification	7
hypothalamus	7
sequence	6
normal	6
menstrual-cycles	6
physical	6
oxidative-stress	6
histopath	6
lps	6
whi	6
mitotic-index	6
predictor	6
overview	6
acid	6
sex	6